Sei Investments Co. Has $322,000 Stake in Amedisys, Inc. (NASDAQ:AMED)

Sei Investments Co. lowered its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 50.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,549 shares of the health services provider’s stock after selling 3,636 shares during the period. Sei Investments Co.’s holdings in Amedisys were worth $322,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Alpine Associates Management Inc. increased its position in Amedisys by 3.2% during the 4th quarter. Alpine Associates Management Inc. now owns 888,120 shares of the health services provider’s stock worth $80,632,000 after buying an additional 27,403 shares during the period. Wealthfront Advisers LLC bought a new position in Amedisys during the fourth quarter worth about $72,970,000. Magnetar Financial LLC increased its position in Amedisys by 0.3% during the fourth quarter. Magnetar Financial LLC now owns 637,443 shares of the health services provider’s stock worth $57,873,000 after acquiring an additional 1,835 shares during the period. Geode Capital Management LLC raised its stake in Amedisys by 1.3% in the 3rd quarter. Geode Capital Management LLC now owns 567,105 shares of the health services provider’s stock worth $54,746,000 after purchasing an additional 7,071 shares in the last quarter. Finally, Pacer Advisors Inc. boosted its holdings in Amedisys by 11,621.9% in the 4th quarter. Pacer Advisors Inc. now owns 558,197 shares of the health services provider’s stock valued at $50,679,000 after purchasing an additional 553,435 shares during the period. 94.36% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Stephens reaffirmed an “equal weight” rating and set a $101.00 target price on shares of Amedisys in a report on Tuesday, March 4th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $101.00.

Amedisys Stock Down 0.6 %

Shares of NASDAQ AMED opened at $91.50 on Friday. Amedisys, Inc. has a 52 week low of $82.15 and a 52 week high of $98.95. The stock’s fifty day moving average is $92.22 and its 200 day moving average is $92.09. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The stock has a market capitalization of $3.00 billion, a P/E ratio of 36.31, a PEG ratio of 1.78 and a beta of 0.89.

Amedisys (NASDAQ:AMED) last released its earnings results on Wednesday, February 26th. The health services provider reported $0.96 EPS for the quarter, missing the consensus estimate of $1.05 by ($0.09). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm had revenue of $598.05 million during the quarter, compared to the consensus estimate of $602.38 million. Sell-side analysts forecast that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.